Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?

Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?

Pancreatic ductal adenocarcinoma (PDAC), accounting for 90–95% of all pancreatic tumors, is a highly devastating disease associated with poor prognosis. The lack of accurate diagnostic tests and failure of conventional therapies contribute to this pejorative issue. Over the last decade, the advent o...

Full description

Bibliographic Details
Main Authors: Christopher Montemagno, Shamir Cassim, Nicolas De Leiris, Jérôme Durivault, Marc Faraggi, Gilles Pagès
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:International Journal of Molecular Sciences
Subjects:
PDAC
nuclear medicine
molecular imaging
internal vectorized radiotherapy
Online Access:https://www.mdpi.com/1422-0067/22/12/6413

Internet

https://www.mdpi.com/1422-0067/22/12/6413

Similar Items